Regulatory T cells, tumour immunity and immunotherapy (original) (raw)

• Shevach, E. M. Fatal attraction: tumours beckon regulatory T cells. Nature Med. 10, 900?901 (2004).
  Article CAS PubMed Google Scholar
• Gershon, R. K. & Kondo, K. Infectious immunological tolerance. Immunology 21, 903?914 (1971).
  CAS PubMed PubMed Central Google Scholar
• Gershon, R. K. & Kondo, K. Cell interactions in the induction of tolerance: the role of thymic lymphocytes. Immunology 18, 723?737 (1970).
  CAS PubMed PubMed Central Google Scholar
• Fujimoto, S., Greene, M. & Sehon, A. H. Immunosuppressor T cells in tumour bearing host. Immunol. Commun. 4, 201?217 (1975).
  Article CAS PubMed Google Scholar
• Berendt, M. J. & North, R. J. T-cell-mediated suppression of anti-tumour immunity. An explanation for progressive growth of an immunogenic tumour. J. Exp. Med. 151, 69?80 (1980).
  Article CAS PubMed Google Scholar
• Bursuker, I. & North, R. J. Generation and decay of the immune response to a progressive fibrosarcoma. II. Failure to demonstrate postexcision immunity after the onset of T cell-mediated suppression of immunity. J. Exp. Med. 159, 1312?1321 (1984).
  Article CAS PubMed Google Scholar
• North, R. J. & Bursuker, I. Generation and decay of the immune response to a progressive fibrosarcoma. I. Ly-1+2− suppressor T cells downregulate the generation of Ly-1−2+ effector T cells. J. Exp. Med. 159, 1295?1311 (1984).
  Article CAS PubMed Google Scholar
• Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. & Toda, M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155, 1151?1164 (1995). This paper proposed CD25 as a surface marker of CD4+ regulatory T cells.
  CAS PubMed Google Scholar
• Hori, S., Nomura, T. & Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057?1061 (2003).
  Article CAS PubMed Google Scholar
• Fontenot, J. D., Gavin, M. A. & Rudensky, A. Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nature Immunol. 4, 330?336 (2003).
  Article CAS Google Scholar
• Khattri, R., Cox, T., Yasayko, S. A. & Ramsdell, F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nature Immunol. 4, 337?342 (2003). References 9?11 provide evidence that FOXP3 is crucial for regulatory T-cell development and function.
  Article CAS Google Scholar
• Groux, H. et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389, 737?742 (1997). The first study showing that functional regulatory T cells can be induced.
  Article CAS PubMed Google Scholar
• Weiner, H. L. Induction and mechanism of action of transforming growth factor-β-secreting Th3 regulatory cells. Immunol. Rev. 182, 207?214 (2001).
  Article CAS PubMed Google Scholar
• Cosmi, L. et al. Human CD8+CD25+ thymocytes share phenotypic and functional features with CD4+CD25+ regulatory thymocytes. Blood 102, 4107?4114 (2003).
  Article CAS PubMed Google Scholar
• Chang, C. C. et al. Tolerization of dendritic cells by TS cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nature Immunol. 3, 237?243 (2002).
  Article CAS Google Scholar
• Rifa'i, M., Kawamoto, Y., Nakashima, I. & Suzuki, H. Essential roles of CD8+CD122+ regulatory T cells in the maintenance of T cell homeostasis. J. Exp. Med. 200, 1123?1134 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Zou, W. et al. Stromal-derived factor-1 in human tumours recruits and alters the function of plasmacytoid precursor dendritic cells. Nature Med. 7, 1339?1346 (2001).
  Article CAS PubMed Google Scholar
• Wei, S. et al. Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma. Cancer Res. 65, 5020?5026 (2005).
  Article CAS PubMed Google Scholar
• Gilliet, M. & Liu, Y. J. Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J. Exp. Med. 195, 695?704 (2002). References 17?19 report that human plasmacytoid dendritic cells can induce CD8+ regulatory T cells.
  Article CAS PubMed PubMed Central Google Scholar
• Shevach, E. M. CD4+ CD25+ suppressor T cells: more questions than answers. Nature Rev. Immunol. 2, 389?400 (2002). An outstanding Review that summarizes recent findings in the field of regulatory T cells and gives an outlook for future direction.
  Article CAS Google Scholar
• Dunn, G. P., Old, L. J. & Schreiber, R. D. The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21, 137?148 (2004). This paper summarizes the most important experimental information to refine and revisit the concept of tumour immune surveillance.
  Article CAS PubMed Google Scholar
• Zou, W. Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nature Rev. Cancer 5, 263?274 (2005).
  Article CAS Google Scholar
• Sakaguchi, S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nature Immunol. 6, 345?352 (2005).
  Article CAS Google Scholar
• Onizuka, S. et al. Tumour rejection by in vivo administration of anti-CD25 (interleukin-2 receptor α) monoclonal antibody. Cancer Res. 59, 3128?3133 (1999).
  CAS PubMed Google Scholar
• Shimizu, J., Yamazaki, S. & Sakaguchi, S. Induction of tumour immunity by removing CD25+CD4+ T cells: a common basis between tumour immunity and autoimmunity. J. Immunol. 163, 5211?5218 (1999). References 24 and 25 are the first reports that depletion of CD25+ cells, probably CD4+CD25+ T cells, improves or promotes tumour immunity in mice.
  CAS PubMed Google Scholar
• van Elsas, A. et al. Elucidating the autoimmune and antitumour effector mechanisms of a treatment based on cytotoxic T lymphocyte antigen-4 blockade in combination with a B16 melanoma vaccine: comparison of prophylaxis and therapy. J. Exp. Med. 194, 481?489 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Sutmuller, R. P. et al. Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25+ regulatory T cells in antitumour therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses. J. Exp. Med. 194, 823?832 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Yu, P. et al. Intratumour depletion of CD4+ cells unmasks tumour immunogenicity leading to the rejection of late-stage tumours. J. Exp. Med. 201, 779?791 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Steitz, J., Bruck, J., Lenz, J., Knop, J. & Tuting, T. Depletion of CD25+CD4+ T cells and treatment with tyrosinase-related protein 2-transduced dendritic cells enhance the interferon α-induced, CD8+ T-cell-dependent immune defense of B16 melanoma. Cancer Res. 61, 8643?8646 (2001).
  CAS PubMed Google Scholar
• Jones, E. et al. Depletion of CD25+ regulatory cells results in suppression of melanoma growth and induction of autoreactivity in mice. Cancer Immun. 2, 1 (2002).
  PubMed Google Scholar
• Tanaka, H., Tanaka, J., Kjaergaard, J. & Shu, S. Depletion of CD4+ CD25+ regulatory cells augments the generation of specific immune T cells in tumour-draining lymph nodes. J. Immunother. 25, 207?217 (2002).
  Article CAS PubMed Google Scholar
• Nagai, H. et al. In vivo elimination of CD25+ regulatory T cells leads to tumour rejection of B16F10 melanoma, when combined with interleukin-12 gene transfer. Exp. Dermatol. 13, 613?620 (2004).
  Article CAS PubMed Google Scholar
• Prasad, S. J. et al. Dendritic cells loaded with stressed tumour cells elicit long-lasting protective tumour immunity in mice depleted of CD4+CD25+ regulatory T cells. J. Immunol. 174, 90?98 (2005).
  Article CAS PubMed Google Scholar
• Ko, K. et al. Treatment of advanced tumours with agonistic anti-GITR mAb and its effects on tumour-infiltrating Foxp3+CD25+CD4+ regulatory T cells. J. Exp. Med. 202, 885?891 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Golgher, D., Jones, E., Powrie, F., Elliott, T. & Gallimore, A. Depletion of CD25+ regulatory cells uncovers immune responses to shared murine tumour rejection antigens. Eur. J. Immunol. 32, 3267?3275 (2002).
  Article CAS PubMed Google Scholar
• Casares, N. et al. CD4+/CD25+ regulatory cells inhibit activation of tumour-primed CD4+ T cells with IFN-γ-dependent antiangiogenic activity, as well as long-lasting tumour immunity elicited by peptide vaccination. J. Immunol. 171, 5931?5939 (2003).
  Article CAS PubMed Google Scholar
• Barnett, B., Kryczek, I., Cheng, P., Zou, W. & Curiel, T. J. Regulatory T cells in ovarian cancer: biology and therapeutic potential. Am. J. Reprod. Immunol. 54, 369?377 (2005).
  Article CAS PubMed Google Scholar
• Dannull, J. et al. Enhancement of vaccine-mediated antitumour immunity in cancer patients after depletion of regulatory T cells. J. Clin. Invest. 115, 3623?3633 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Attia, P., Maker, A. V., Haworth, L. R., Rogers-Freezer, L. & Rosenberg, S. A. Inability of a fusion protein of IL-2 and diphtheria toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to eliminate regulatory T lymphocytes in patients with melanoma. J. Immunother. 28, 582?592 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Curiel, T. J. et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nature Med. 10, 942?949 (2004).
  Article CAS PubMed Google Scholar
• Turk, M. J., Guevara-Patino, J. A., Rizzuto, G. A., Engelhorn, M. E. & Houghton, A. N. Concomitant tumour immunity to a poorly immunogenic melanoma is prevented by regulatory T cells. J. Exp. Med. 200, 771?782 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Antony, P. A. et al. CD8+ T cell immunity against a tumour/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells. J. Immunol. 174, 2591?601 (2005). References 40, 41 and 42 provide a direct functional link between CD4+CD25+ T cells and tumour immunopathogenesis in tumour patients and in tumour-bearing mice, respectively.
  Article CAS PubMed Google Scholar
• Shimizu, J., Yamazaki, S., Takahashi, T., Ishida, Y. & Sakaguchi, S. Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance. Nature Immunol. 3, 135?142 (2002).
  Article CAS Google Scholar
• Read, S., Malmstrom, V. & Powrie, F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25+CD4+ regulatory cells that control intestinal inflammation. J. Exp. Med. 192, 295?302 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Takahashi, T. et al. Immunologic self-tolerance maintained by CD25+CD4+ regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192, 303?310 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Leach, D. R., Krummel, M. F. & Allison, J. P. Enhancement of antitumour immunity by CTLA-4 blockade. Science 271, 1734?1736 (1996).
  Article CAS PubMed Google Scholar
• Kwon, E. D. et al. Manipulation of T cell co-stimulatory and inhibitory signals for immunotherapy of prostate cancer. Proc. Natl Acad. Sci. USA 94, 8099?8103 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Kwon, E. D. et al. Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy. Proc. Natl Acad. Sci. USA 96, 15074?15079 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Hurwitz, A. A. et al. Combination immunotherapy of primary prostate cancer in a transgenic mouse model using CTLA-4 blockade. Cancer Res. 60, 2444?2448 (2000).
  CAS PubMed Google Scholar
• Hurwitz, A. A., Yu, T. F., Leach, D. R. & Allison, J. P. CTLA-4 blockade synergizes with tumour-derived granulocyte-macrophage colony-stimulating factor for treatment of an experimental mammary carcinoma. Proc. Natl Acad. Sci. USA 95, 10067?10071 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• van Elsas, A., Hurwitz, A. A. & Allison, J. P. Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumours accompanied by autoimmune depigmentation. J. Exp. Med. 190, 355?366 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Espenschied, J. et al. CTLA-4 blockade enhances the therapeutic effect of an attenuated poxvirus vaccine targeting p53 in an established murine tumour model. J. Immunol. 170, 3401?3407 (2003).
  Article CAS PubMed Google Scholar
• Phan, G. Q. et al. Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma. Proc. Natl Acad. Sci. USA 100, 8372?8377 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Hodi, F. S. et al. Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients. Proc. Natl Acad. Sci. USA 100, 4712?4717 (2003). References 53 and 54 report clinical trials that show that CTLA4 blockade can induce tumour regression as well as severe, but manageable, autoimmune diseases in patients with tumours.
  Article CAS PubMed PubMed Central Google Scholar
• Maker, A. V., Attia, P. & Rosenberg, S. A. Analysis of the cellular mechanism of antitumour responses and autoimmunity in patients treated with CTLA-4 blockade. J. Immunol. 175, 7746?7754 (2005).
  Article CAS PubMed Google Scholar
• Tang, Q. et al. Distinct roles of CTLA-4 and TGF-β in CD4+CD25+ regulatory T cell function. Eur. J. Immunol. 34, 2996?3005 (2004).
  Article CAS PubMed Google Scholar
• Rollinghoff, M., Starzinski-Powitz, A., Pfizenmaier, K. & Wagner, H. Cyclophosphamide-sensitive T lymphocytes suppress the in vivo generation of antigen-specific cytotoxic T lymphocytes. J. Exp. Med. 145, 455?459 (1977).
  Article CAS PubMed PubMed Central Google Scholar
• Glaser, M. Augmentation of specific immune response against a syngeneic SV40-induced sarcoma in mice by depletion of suppressor T cells with cyclophosphamide. Cell Immunol. 48, 339?345 (1979).
  Article CAS PubMed Google Scholar
• Yoshida, S., Nomoto, K., Himeno, K. & Takeya, K. Immune response to syngeneic or autologous testicular cells in mice. I. Augmented delayed footpad reaction in cyclophosphamide-treated mice. Clin. Exp. Immunol. 38, 211?217 (1979).
  CAS PubMed PubMed Central Google Scholar
• Berd, D. & Mastrangelo, M. J. Effect of low dose cyclophosphamide on the immune system of cancer patients: depletion of CD4+, 2H4+ suppressor-inducer T-cells. Cancer Res. 48, 1671?1675 (1988).
  CAS PubMed Google Scholar
• Awwad, M. & North, R. J. Cyclophosphamide-induced immunologically mediated regression of a cyclophosphamide-resistant murine tumour: a consequence of eliminating precursor L3T4+ suppressor T-cells. Cancer Res. 49, 1649?1654 (1989).
  CAS PubMed Google Scholar
• Awwad, M. & North, R. J. Cyclophosphamide (Cy)-facilitated adoptive immunotherapy of a Cy-resistant tumour. Evidence that Cy permits the expression of adoptive T-cell mediated immunity by removing suppressor T cells rather than by reducing tumour burden. Immunology 65, 87?92 (1988).
  CAS PubMed PubMed Central Google Scholar
• Lutsiak, M. E. et al. Inhibition of CD4+25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide. Blood 105, 2862?2868 (2005).
  Article CAS PubMed Google Scholar
• Ercolini, A. M. et al. Recruitment of latent pools of high-avidity CD8+T cells to the antitumour immune response. J. Exp. Med. 201, 1591?1602 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Ghiringhelli, F. et al. CD4+CD25+ regulatory T cells suppress tumour immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumours to be curative. Eur. J. Immunol. 34, 336?344 (2004).
  Article CAS PubMed Google Scholar
• Zhang, H. et al. Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+regulatory T cells. Nature Med. 11, 1238?1243 (2005).
  Article CAS PubMed Google Scholar
• Von Herrath, M. G. & Harrison, L. C. Regulatory Lymphocytes: antigen-induced regulatory T cells in autoimmunity. Nature Rev. Immunol. 3, 223?232 (2003).
  Article CAS Google Scholar
• Khong, H. T. & Restifo, N. P. Natural selection of tumour variants in the generation of 'tumour escape' phenotypes. Nature Immunol. 3, 999?1005 (2002). An outstanding review of tumour immune-evasion mechanisms.
  Article CAS Google Scholar
• Woo, E. Y. et al. Regulatory CD4+CD25+ T cells in tumours from patients with early- stage non-small cell lung cancer and late-stage ovarian cancer. Cancer Res. 61, 4766?4772 (2001). The first demonstration that CD4+CD25+ T cells are increased in patients with tumours and can suppress T-cell activation in vitro.
  CAS PubMed Google Scholar
• Liyanage, U. K. et al. Prevalence of regulatory T cells is increased in peripheral blood and tumour microenvironment of patients with pancreas or breast adenocarcinoma. J. Immunol. 169, 2756?2761 (2002).
  Article CAS PubMed Google Scholar
• Somasundaram, R. et al. Inhibition of cytolytic T lymphocyte proliferation by autologous CD4+/CD25+ regulatory T cells in a colorectal carcinoma patient is mediated by transforming growth factor-β. Cancer Res. 62, 5267?5272 (2002).
  CAS PubMed Google Scholar
• Wolf, A. M. et al. Increase of regulatory T cells in the peripheral blood of cancer patients. Clin. Cancer Res. 9, 606?612 (2003).
  PubMed Google Scholar
• Ichihara, F. et al. Increased populations of regulatory T cells in peripheral blood and tumour-infiltrating lymphocytes in patients with gastric and esophageal cancers. Clin. Cancer Res. 9, 4404?4408 (2003).
  PubMed Google Scholar
• Sasada, T., Kimura, M., Yoshida, Y., Kanai, M. & Takabayashi, A. CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression. Cancer 98, 1089?1099 (2003).
  Article PubMed Google Scholar
• Ormandy, L. A. et al. Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma. Cancer Res. 65, 2457?2464 (2005).
  Article CAS PubMed Google Scholar
• Karube, K. et al. Expression of FoxP3, a key molecule in CD4CD25 regulatory T cells, in adult T-cell leukaemia/lymphoma cells. Br. J. Haematol. 126, 81?84 (2004).
  Article CAS PubMed Google Scholar
• Marshall, N. A. et al. Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma. Blood 103, 1755?1762 (2004).
  Article CAS PubMed Google Scholar
• Viguier, M. et al. Foxp3 expressing CD4+CD25high regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells. J. Immunol. 173, 1444?1453 (2004).
  Article CAS PubMed Google Scholar
• Gray, C. P., Arosio, P. & Hersey, P. Association of increased levels of heavy-chain ferritin with increased CD4+ CD25+ regulatory T-cell levels in patients with melanoma. Clin. Cancer Res. 9, 2551?2559 (2003).
  CAS PubMed Google Scholar
• Viglietta, V., Baecher-Allan, C., Weiner, H. L. & Hafler, D. A. Loss of functional suppression by CD4+ CD25+ regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 199, 971?979 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Kriegel, M. A. et al. Defective suppressor function of human CD4+ CD25+ regulatory T cells in autoimmune polyglandular syndrome type II. J. Exp. Med. 199, 1285?1291 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Ehrenstein, M. R. et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFα therapy. J. Exp. Med. 200, 277?285 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Fontenot, J. D. et al. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22, 329?341 (2005).
  Article CAS PubMed Google Scholar
• Zou, L. et al. Bone marrow is a reservoir for CD4+ CD25+ regulatory T cells that traffic through CXCL12/CXCR4 signals. Cancer Res. 64, 8451?8455 (2004).
  Article CAS PubMed Google Scholar
• Gabrilovich, D. Mechanisms and functional significance of tumour-induced dendritic-cell defects. Nature Rev. Immunol. 4, 941?952 (2004).
  Article CAS Google Scholar
• Jonuleit, H., Schmitt, E., Schuler, G., Knop, J. & Enk, A. H. Induction of interleukin 10-producing, nonproliferating CD4+ T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 192, 1213?1222 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Dhodapkar, M. V., Steinman, R. M., Krasovsky, J., Munz, C. & Bhardwaj, N. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J. Exp. Med. 193, 233?238 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Chakraborty, N. G., Chattopadhyay, S., Mehrotra, S., Chhabra, A. & Mukherji, B. Regulatory T-cell response and tumour vaccine-induced cytotoxic T lymphocytes in human melanoma. Hum. Immunol. 65, 794?802 (2004). References 86?88 and 143 provide evidence that APCs can induce regulatory T cells in humans.
  Article CAS PubMed Google Scholar
• Ghiringhelli, F. et al. Tumour cells convert immature myeloid dendritic cells into TGF-β-secreting cells inducing CD4+CD25+ regulatory T cell proliferation. J. Exp. Med. 202, 919?929 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Yamazaki, S. et al. Direct expansion of functional CD4+CD25+ regulatory T cells by antigen-processing dendritic cells. J. Exp. Med. 198, 235?247 (2003).
  CAS PubMed PubMed Central Google Scholar
• Tarbell, K. V., Yamazaki, S., Olson, K., Toy, P. & Steinman, R. M. CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J. Exp. Med. 199, 1467?1477 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Chen, W. et al. Conversion of peripheral CD4+CD25− naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198, 1875?1886 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Curotto de Lafaille, M. A., Lino, A. C., Kutchukhidze, N. & Lafaille, J. J. CD25− T cells generate CD25+Foxp3+ regulatory T cells by peripheral expansion. J. Immunol. 173, 7259?7268 (2004).
  Article CAS PubMed Google Scholar
• Fantini, M. C. et al. Cutting edge: TGF-β induces a regulatory phenotype in CD4+CD25−T cells through Foxp3 induction and downregulation of Smad7. J. Immunol. 172, 5149?5153 (2004).
  Article CAS PubMed Google Scholar
• Liang, S. et al. Conversion of CD4+ CD25− cells into CD4+ CD25+ regulatory T cells in vivo requires B7 co-stimulation, but not the thymus. J. Exp. Med. 201, 127?137 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Wan, Y. Y. & Flavell, R. A. Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc. Natl Acad. Sci. USA 102, 5126?5131 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Seo, N., Hayakawa, S., Takigawa, M. & Tokura, Y. Interleukin-10 expressed at early tumour sites induces subsequent generation of CD4+ T-regulatory cells and systemic collapse of antitumour immunity. Immunology 103, 449?457 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Moller, G. Do suppressor T cells exist? Scand J. Immunol. 27, 247?250 (1988).
  Article CAS PubMed Google Scholar
• Wang, H. Y. et al. Tumour-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy. Immunity 20, 107?118 (2004). The first study demonstrating TAA-specific ligand for CD4+CD25+ T cells in human cancer.
  Article CAS PubMed Google Scholar
• Hawrylowicz, C. M. & O'Garra, A. Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma. Nature Rev. Immunol. 5, 271?283 (2005).
  Article CAS Google Scholar
• Hsieh, C. S. et al. Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors. Immunity 21, 267?277 (2004).
  Article CAS PubMed Google Scholar
• Zhou, G., Lu, Z., McCadden, J. D., Levitsky, H. I. & Marson, A. L. Reciprocal changes in tumour antigenicity and antigen-specific T cell function during tumour progression. J. Exp. Med. 200, 1581?1592 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Ghiringhelli, F. et al. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-β-dependent manner. J. Exp. Med. 202, 1075?1085 (2005). The first in vivo study demonstrating a role of CD4+CD25+ T cells in blunting the NK-cell arm of the innate immune system in tumour immunity.
  Article CAS PubMed PubMed Central Google Scholar
• Chen, M. L. et al. Regulatory T cells suppress tumour-specific CD8 T cell cytotoxicity through TGF-β signals in vivo. Proc. Natl Acad. Sci. USA 102, 419?424 (2005).
  Article CAS PubMed Google Scholar
• Peng, Y., Laouar, Y., Li, M. O., Green, E. A. & Flavell, R. A. TGF-β regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes. Proc. Natl Acad. Sci. USA 101, 4572?4577 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Green, E. A., Gorelik, L., McGregor, C. M., Tran, E. H. & Flavell, R. A. CD4+CD25+ T regulatory cells control anti-islet CD8+ T cells through TGF-β-TGF-β receptor interactions in type 1 diabetes. Proc. Natl Acad. Sci. USA 100, 10878?10883 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Kryczek, I. et al. B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma. J. Exp. Med. (in the press).
• Kryczek, I. et al. Induction of B7-H4 on antigen presenting cells through interleukin 10: novel suppressive mode for regulatory T cells. J. Immunol. (in the press).
• von Boehmer, H. Mechanisms of suppression by suppressor T cells. Nature Immunol. 6, 338?344 (2005).
  Article CAS Google Scholar
• de la Rosa, M., Rutz, S., Dorninger, H. & Scheffold, A. Interleukin-2 is essential for CD4+CD25+ regulatory T cell function. Eur. J. Immunol. 34, 2480?2488 (2004).
  Article CAS PubMed Google Scholar
• Grossman, W. J. et al. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 21, 589?601 (2004).
  Article CAS PubMed Google Scholar
• Gondek, D. C., Lu, L. F., Quezada, S. A., Sakaguchi, S. & Noelle, R. J. Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J. Immunol. 174, 1783?1786 (2005).
  Article CAS PubMed Google Scholar
• Mellor, A. L. & Munn, D. H. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nature Rev. Immunol. 4, 762?774 (2004).
  Article CAS Google Scholar
• Fallarino, F. et al. Modulation of tryptophan catabolism by regulatory T cells. Nature Immunol. 4, 1206?1212 (2003).
  Article CAS Google Scholar
• Sica, G. L. et al. B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. Immunity 18, 849?861 (2003).
  Article CAS PubMed Google Scholar
• Zang, X. et al. B7x: a widely expressed B7 family member that inhibits T cell activation. Proc. Natl Acad. Sci. USA 100, 10388?10392 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Prasad, D. V., Richards, S., Mai, X. M. & Dong, C. B7S1, a novel B7 family member that negatively regulates T cell activation. Immunity 18, 863?873 (2003).
  Article CAS PubMed Google Scholar
• Nishikawa, H. et al. Definition of target antigens for naturally occurring CD4+CD25+ regulatory T cells. J. Exp. Med. 201, 681?686 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Nishikawa, H., Jager, E., Ritter, G., Old, L. J. & Gnjatic, S. CD4+ CD25+ regulatory T cells control the induction of antigen-specific CD4+ helper T cell responses in cancer patients. Blood 106, 1008?1011 (2005).
  Article CAS PubMed Google Scholar
• Apostolou, I., Sarukhan, A., Klein, L. & von Boehmer, H. Origin of regulatory T cells with known specificity for antigen. Nature Immunol. 3, 756?763 (2002).
  Article CAS Google Scholar
• Zhou, G., Drake, C. G. & Levitsky, H. I. Amplification of tumour-specific regulatory T cells following therapeutic cancer vaccines. Blood 107, 628?636 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Thornton, A. M. & Shevach, E. M. Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific. J. Immunol. 164, 183?190 (2000).
  Article CAS PubMed Google Scholar
• Foss, F. M. DAB389 IL-2 (ONTAK): a novel fusion toxin therapy for lymphoma. Clin. Lymphoma 1, 110?116 (2000).
  Article CAS PubMed Google Scholar
• Shibutani, S. et al. Effects of immunosuppressants on induction of regulatory cells after intratracheal delivery of alloantigen. Transplantation 79, 904?913 (2005).
  Article CAS PubMed Google Scholar
• Kawai, M., Kitade, H., Mathieu, C., Waer, M. & Pirenne, J. Inhibitory and stimulatory effects of cyclosporine A on the development of regulatory T cells in vivo. Transplantation 79, 1073?1077 (2005).
  Article CAS PubMed Google Scholar
• Furtado, G. C., Curotto de Lafaille, M. A., Kutchukhidze, N. & Lafaille, J. J. Interleukin 2 signalling is required for CD4+regulatory T cell function. J. Exp. Med. 196, 851?857 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Malek, T. R. & Bayer, A. L. Tolerance, not immunity, crucially depends on IL-2. Nature Rev. Immunol. 4, 665?674 (2004).
  Article CAS Google Scholar
• Bayer, A. L., Yu, A., Adeegbe, D. & Malek, T. R. Essential role for interleukin-2 for CD4+CD25+ T regulatory cell development during the neonatal period. J. Exp. Med. 201, 769?777 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Setoguchi, R., Hori, S., Takahashi, T. & Sakaguchi, S. Homeostatic maintenance of natural Foxp3+CD25+CD4+ regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J. Exp. Med. 201, 723?735 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Thornton, A. M., Donovan, E. E., Piccirillo, C. A. & Shevach, E. M. Cutting edge: IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function. J. Immunol. 172, 6519?6523 (2004).
  Article CAS PubMed Google Scholar
• Antony, P. A. & Restifo, N. P. CD4+CD25+ T regulatory cells, immunotherapy of cancer, and interleukin-2. J. Immunother. 28, 120?128 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Finn, O. J. Cancer vaccines: between the idea and the reality. Nature Rev. Immunol. 3, 630?641 (2003). An outstanding and comprehensive review of the development of vaccination and immunotherapy for cancer. It proposes that cancer vaccines must overcome immune suppression.
  Article CAS Google Scholar
• Sereti, I. et al. IL-2-induced CD4+ T-cell expansion in HIV-infected patients is associated with long-term decreases in T-cell proliferation. Blood 104, 775?780 (2004).
  Article CAS PubMed Google Scholar
• Ahmadzadeh, M. & Rosenberg, S. A. IL-2 administration increases CD4+CD25hiFoxp3+ regulatory T cells in cancer patients. Blood 107, 2409?2414 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Kryczek, I. et al. CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers. Cancer Res. 65, 465?472 (2005).
  CAS PubMed Google Scholar
• Klebanoff, C. A. et al. IL-15 enhances the in vivo antitumour activity of tumour-reactive CD8+ T cells. Proc. Natl Acad. Sci. USA 101, 1969?1974 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Zeng, R. et al. Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function. J. Exp. Med. 201, 139?148 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Melchionda, F. et al. Adjuvant IL-7 or IL-15 overcomes immunodominance and improves survival of the CD8+ memory cell pool. J. Clin. Invest. 115, 1177?1187 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Ruprecht, C. R. et al. Co-expression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia. J. Exp. Med. 201, 1793?1803 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Verginis, P., Li, H. S. & Carayanniotis, G. Tolerogenic semimature dendritic cells suppress experimental autoimmune thyroiditis by activation of thyroglobulin-specific CD4+CD25+ T cells. J. Immunol. 174, 7433?7439 (2005).
  Article CAS PubMed Google Scholar
• Wakkach, A. et al. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 18, 605?617 (2003).
  Article CAS PubMed Google Scholar
• Lutz, M. B. & Schuler, G. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol. 23, 445?449 (2002).
  Article CAS PubMed Google Scholar
• Dhodapkar, M. V. & Steinman, R. M. Antigen-bearing immature dendritic cells induce peptide-specific CD8+ regulatory T cells in vivo in humans. Blood 100, 174?177 (2002).
  Article CAS PubMed Google Scholar
• Lundqvist, A., Palmborg, A., Pavlenko, M., Levitskaya, J. & Pisa, P. Mature dendritic cells induce tumour-specific type 1 regulatory T cells. J. Immunother. 28, 229?235 (2005).
  Article CAS PubMed Google Scholar
• Wickelgren, I. Immunology. Policing the immune system. Science 306, 596?599 (2004).
  Article CAS PubMed Google Scholar